DMAC
NASDAQ · Biotechnology
Diamedica Therapeutics Inc
$7.29
+0.53 (+7.84%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-42.9% upside
Low Target
$2.49
Average Target
$4.16
High Target
$4.48
Current Price
$7.29
Current
$7.29
$7.29
Target
$4.16
$4.16
$2.49
$4.16 avg
$4.48
Scenario Analysis
Bear Case
$2.49
-65.8%
Low target
Base Case
$4.16
-42.9%
Avg target
Bull Case
$4.48
+-38.5%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$10.42
-30.0% from high
52-Week Low
$3.19
+128.5% from low
Target vs 52W High
$4.16
-60.1% vs high
Next Earnings Report
Mar 30, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.18
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |